This study is testing a new diagnostic tool called the RNA Disruption Assay (RDA). It aims to see if a small tumor biopsy taken about a month after starting chemotherapy can accurately predict whether the treatment is working to eliminate the cancer. The goal is to help doctors i…
Phase: NA • Sponsor: Rna Diagnostics Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC